ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,511.40
-0.11%
S&P ASX All Technology
4,034.50
0.55%
Brent Oil
74.565
0.00%
US Dollar vs AUD
1.5949
0.00%
Bitcoin
96,876.23
0.43%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX

  6. Australian Clinical Labs Limited (ACL) Share Price

Australian Clinical Labs Limited

Australian Clinical Labs Limited (ACL)

ASX
3.68
-0.02
(-0.54%)
Closed 09 February 4:00PM
Delayed by 20 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.68
Bid
3.67
Offer
3.75
Volume
136,136
3.67 Day's Range 3.73
2.14 52 Week Range 3.855
Market Cap
742.749M
Previous Close
3.70
Open
3.69
Last Trade
2
@
3.68
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
522,262
Shares Outstanding
201,834,015
Dividend Yield
-
PE Ratio
31.03
Earnings Per Share (EPS)
0.12
Revenue
697.54M
Net Profit
23.93M

About Australian Clinical Labs Limited

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
clinicallabs.com.au/offer
Headquarters
Melbourne, Victoria, Aus
Founded
-
Australian Clinical Labs Limited is listed in the Medical Laboratories sector of the Australian Stock Exchange with ticker ACL. The last closing price for Australian Clinical Labs was AUD3.70. Over the last year, Australian Clinical Labs shares have traded in a share price range of AUD 2.14 to AUD 3.855.

Australian Clinical Labs currently has 201,834,015 shares in issue. The market capitalisation of Australian Clinical Labs is AUD746.79 million. Australian Clinical Labs has a price to earnings ratio (PE ratio) of 31.03.

Ask ADVFN Intelligence (AI)

ACL Latest News

More News

Alchemia Limited slammed 53%: Is the stock a buy?

http://www.fool.com.au/2015/05/29/alchemia-limited-slammed-53-is-the-stock-a-buy/

29 May 2015
The Motley Fool

Alchemia Announces Initiation of Phase II Trial in Small Cell Lung Cancer

Alchemia Limited (ASX:ACL), today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug HA-Irinotecan in Small Cell Lung Cancer (SCLC...

12 September 2011
Business Wire

UPDATE: Dr Reddy's Gets US OK For Generic Anticlotting Injection

Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received U.S. regulatory approval to launch a copy of GlaxoSmithKline PLC's (GSK) anticlotting Arixtra injection, which is expected...

13 July 2011
Dow Jones News

Dr. Reddy’s Announces the USFDA Approval of Fondaparinux Sodium Injection

Dr. Reddy’s Laboratories (NYSE: RDY) and Alchemia Limited, Brisbane, Australia (ASX: ACL) announced today that Dr. Reddy’s has received final approval of Dr. Reddy’s ANDA for...

13 July 2011
Business Wire

Dr Reddy's Gets US OK To Sell Generic Injection To Prevent Blood Clots

Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday it has received final approval from the U.S. Food and Drug Administration to sell a generic version of GlaxoSmithKline PLC's (GSK) Arixtra...

13 July 2011
Dow Jones News

Alchemia to Present at Cowen and Company 31st Annual Health Care Conference

Alchemia Limited (ASX: ACL) announced today that Pete Smith, Chief Executive Officer, is scheduled to present a corporate update at the Cowen and Company 31st Annual Health Care...

05 March 2011
Business Wire

Alchemia and Dr Reddy’s Expand Fondaparinux Marketing Collaboration

Alchemia (ASX:ACL) today announced the agreement of terms with Dr Reddy’s Limited for marketing fondaparinux sodium for injection (the generic version of GlaxoSmithKline’s...

15 July 2010
Business Wire

Alchemia’s HyACT Technology Enhances the Killing of Cancer Stem Cell Populations in Breast and Colorectal Cancer

Alchemia’s (ASX: ACL) subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The...

21 April 2010
Business Wire

Emisphere Technologies and Alchemia to Research an Oral Formulation of Fondaparinux with Eligen® Technology

Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) today announced that they are joining efforts to develop an oral formulation of the anti-coagulant drug...

18 March 2010
Business Wire

CORRECT: Alcon 3Q Profit Down 18%, Raises 2009 Earnings View

("Alcon 3Q Profit Down 18%, Raises 2009 Earnings View 2nd Time," published at 6:12 p.m. EDT, incorrectly included a tax benefit for the latest quarter. The correct version follows.) DOW JONES...

28 October 2009
Dow Jones News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.030.8219178082193.653.833.614245243.72255828DE
40.216.051873198853.473.833.345014913.53358475DE
120.133.661971830993.553.833.295222623.50893859DE
261.2350.20408163272.453.8552.388361763.40253499DE
520.7626.02739726032.923.8552.147919532.97011394DE
156-1.35-26.83896620285.035.882.147037473.49229212DE
2603.66933354.54545450.0116.390.0116967333.65190253DE

ACL - Frequently Asked Questions (FAQ)

What is the current Australian Clinical Labs share price?
The current share price of Australian Clinical Labs is AUD 3.68
How many Australian Clinical Labs shares are in issue?
Australian Clinical Labs has 201,834,015 shares in issue
What is the market cap of Australian Clinical Labs?
The market capitalisation of Australian Clinical Labs is AUD 746.79M
What is the 1 year trading range for Australian Clinical Labs share price?
Australian Clinical Labs has traded in the range of AUD 2.14 to AUD 3.855 during the past year
What is the PE ratio of Australian Clinical Labs?
The price to earnings ratio of Australian Clinical Labs is 31.03
What is the cash to sales ratio of Australian Clinical Labs?
The cash to sales ratio of Australian Clinical Labs is 1.06
What is the reporting currency for Australian Clinical Labs?
Australian Clinical Labs reports financial results in AUD
What is the latest annual turnover for Australian Clinical Labs?
The latest annual turnover of Australian Clinical Labs is AUD 697.54M
What is the latest annual profit for Australian Clinical Labs?
The latest annual profit of Australian Clinical Labs is AUD 23.93M
What is the registered address of Australian Clinical Labs?
The registered address for Australian Clinical Labs is 1868-1892 DANDENONG ROAD, CLAYTON, MELBOURNE, VICTORIA, 3168
What is the Australian Clinical Labs website address?
The website address for Australian Clinical Labs is clinicallabs.com.au/offer
Which industry sector does Australian Clinical Labs operate in?
Australian Clinical Labs operates in the MEDICAL LABORATORIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KALKalgoorlie Gold Mining Ltd
AUD 0.086
(273.91%)
100.5M
E79E79 Gold Mines Ltd
AUD 0.038
(100.00%)
14.68M
SLZOSultan Resources Ltd
AUD 0.002
(100.00%)
335.71k
TMSOTennant Minerals Ltd
AUD 0.002
(100.00%)
500k
BP8BPH Global Ltd
AUD 0.003
(50.00%)
1.45M
NACONAOS Ex50 Opportunities Company Limited
AUD 0.001
(-50.00%)
31.7k
ADNOCAndromeda Metals Limited
AUD 0.001
(-50.00%)
750k
VPRVolt Group Ltd
AUD 0.001
(-50.00%)
300.11k
EELENRG Elements Ltd
AUD 0.001
(-50.00%)
1.05M
UNTOAUnith Ltd
AUD 0.003
(-40.00%)
50k
1TTThrive Tribe Technologies Ltd
AUD 0.002
(-33.33%)
145.77M
KALKalgoorlie Gold Mining Ltd
AUD 0.086
(273.91%)
100.5M
SYASayona Mining Limited
AUD 0.025
(2.04%)
98.07M
MYRMyer Holdings Limited
AUD 0.89
(5.33%)
65.63M
POSPoseidon Nickel Limited
AUD 0.0055
(22.22%)
57.15M

Discussion

View Full Feed
capgain capgain 5 minutes ago
So, the Nashville boys did a couple of shows this weekend in Chicago. Jedd decided to play that John Hartford Tune!

https://www.youtube.com/watch?v=SKezWbgiJPk
baltimorebullet baltimorebullet 9 minutes ago
Weight-loss drug may slow Alzheimer’s decline.

https://www.imperial.ac.uk/news/255214/weight-loss-drug-slow-alzheimers-decline/

This could end up like VHS vs Betamax (we're Betamax).
AVXL
capgain capgain 12 minutes ago
Good morning, Larry.
capgain capgain 13 minutes ago
Bryan Sutton & Chris Eldridge "Eastbound and Down" GMBR 2024

https://www.youtube.com/watch?v=u9wPulvuhC8
capgain capgain 18 minutes ago
Billy Strings and Bryan Sutton

https://www.youtube.com/watch?v=K6eGnZEoHC8
capgain capgain 21 minutes ago
Love it, Bull. The future is looking brighter.
Seminole Red Seminole Red 24 minutes ago
Duffy: I Think We Have Generals Using Helicopters as ‘Personal Ubers’, That’s Wasteful and Dangerous

https://www.breitbart.com/politics/2025/02/07/duffy-i-think-we-have-generals-using-helicopters-as-personal-ubers-thats-wasteful-and-dangerous/?utm_source=facebook&utm_medium=social&fbc
Bull_Dolphin Bull_Dolphin 24 minutes ago
Gov torture of disabled vet:

https://x.com/OKPrayinPatriot/status/1887928623295803472
LVerstee LVerstee 26 minutes ago
A perfect description of yourself. Couldn't be more to the point.

But there is one thing I have learned through the years. Which is that the so-called "critics" out there will never be satisfied no matter how much evidence you shove down their throats.

These people wil
ITUP
FUNYMUNY FUNYMUNY 27 minutes ago
They will just keep milking the sheep that buy into this failure. They have NOTHING but shares to sell. Buyer beware
PPCBD
SEV123 SEV123 28 minutes ago
And yet my friend, once again you refuse to answer what's more important. You said something was coming but you've made promises in the past as Future and as Silicon and nothing has ever come of it.
SEV
Idiot Mayor Idiot Mayor 32 minutes ago
FIVE…… FIVE MORE DAYS!!! On Friday, you will either be vindicated or you will be buried. On Monday you will either be broke and FRANTICALLY seeking a new, plausible explanation to keep the desperate hope alive or you will be counting your billions as the naked shorts scramble to cover this up to dol
DBMM
Bob Mullet Bob Mullet 43 minutes ago
Still posting the Boiler Room party line?

People laugh at you 🤦🏻‍♂️ 

Keep it up!!?!
KBLB
Bull_Dolphin Bull_Dolphin 43 minutes ago
Good morning Larry, another great day!
Bull_Dolphin Bull_Dolphin 44 minutes ago
Stephen Miller goes off:

https://x.com/JackPosobiec/status/1887970744526569638
SkeBallLarry SkeBallLarry 46 minutes ago
" a Brilliant move ~ Good Sabbath Morn', Bull "
vator vator 1 hour ago
style="caret-color: rgb(0, 29, 53); color: rgba(0, 29, 53, 1); font-family: "Google Sans", Roboto, "Helvetica Neue", sans-serif; font-size: 18px"an estimated 704,000 new cancer cases are expected in Brazil eac
NWBO
thecrusher2011 thecrusher2011 2 hours ago
Oh now you've hurt my feelings. Not trying to brag or anything but I'll have you know I went to Tijuana once
marcis marcis 2 hours ago
This is exactly your motivation here.
500 million borrowed ( short ) shares, sell two tick down to .0006 is already is a fast $100,000

Down to 4 or 5 you get a big bonus plus

No wonder the passion to be on your point all weekend and night

I say t
RDAR
Testpilot Testpilot 2 hours ago
I see that sales only dropped by .46%, however the operating income, Net income from continuing operation before income tax, along with Net income fell by -22.99%, -88.36%, and -94.40% respectively. The company submitted a vague explanation "Recognizing subsidiary equity loss and impairment" as to
CRTG
nshi2 nshi2 2 hours ago
https://youtu.be/2xE4bopeXhw
LWLG
thecrusher2011 thecrusher2011 2 hours ago
😂😂😂😂 you're still mad that I noticed all liberals are feminine

Your Recent History

ASX
ACL
Australian Clinical Labs
DOWI
DJSEZ40D
DJ Sustainability Eurozo...
LSE
67VC
Ab Sveriges 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads